Synonyms:
Status: Phase 2
Entry Type: Unknown
Molecule Category: UNKNOWN
UNII: T0N62K2M2Y

Pharmacology

Action Mechanism of Action Reference
BINDING AGENT B-lymphocyte antigen CD20 binding agent PubMed PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Arthritis, Rheumatoid 2 D001172 ClinicalTrials
Lymphoma 1 D008223 ClinicalTrials
Lupus Erythematosus, Systemic 1 D008180 ClinicalTrials

Cross References

Resources Reference
CAS NUMBER 1169717-01-4
ChEMBL CHEMBL4297845
FDA SRS T0N62K2M2Y